Effects of Recombinant Human Tumor Necrosis Factor-α and Its Combination with Native Human Leukocyte Interferon-α on P3-X63- Ag8.653 Mouse Myeloma Cell Growth

QR Code

Effects of Recombinant Human Tumor Necrosis Factor-α and Its Combination with Native Human Leukocyte Interferon-α on P3-X63- Ag8.653 Mouse Myeloma Cell Growth

None

Saved in:

Bibliographic Details
Main Authors:	Plesničar, Andrej, Vidmar, Gaj, Štabuc, Borut, Plesničar, Blanka Kores
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/26501
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Early Detection and Prevention of Breast Cancer: The Increasing Importance of Midwives in the Future
by: Plesničar, Andrej, et al.
Published: (2012)

Tumor necrosis factor α (TNFα) role in the development of metabolic disturbances and atherosclerosis and TNFα antagonists influence on them in patients with rheumatic diseases
by: M S Eliseev, et al.
Published: (2009-04-01)

Use of inhibitors of tumor necrosis factor α in women with ankylosing spondylitis
by: O. A. Krichevskaya, et al.
Published: (2021-10-01)

The tumor necrosis factor-α inhibitor golimumab in the treatment of rheumatoid arthritis
by: Natalia Vladimirovna Chichasova
Published: (2014-12-01)

Anti-Tumour Necrosis Factor-α Induced Systemic Lupus Erythematosus
by: Almoallim, Hani, et al.
Published: (2012)

The system of tumor necrosis factor α in the pathogenesis of autoimmune diabetes mellitus
by: T. S. Prokhorenko, et al.
Published: (2011-02-01)

Infectious Complications of Anti-Tumour Necrosis Factor-α Therapy in Rheumatoid Arthritis
by: Xynos, Ioannis D., et al.
Published: (2012)

THE USE OF TUMOR NECROSIS FACTOR α INHIBITORS IN PATIENTS WITH WEBER-CHRISTIAN DISEASE
by: Olga Nikolayevna Egorova, et al.
Published: (2014-02-01)

The Prospects of tumor necrosis factor α inhibitors use in patients with COVID-19
by: E. S. Aronova, et al.
Published: (2021-04-01)

Incidence of Toxoplasmosis in Psoriasis Patients and Possible Correlation with Tumor Necrosis Factor-α
by: Entsar J. Saheb, et al.
Published: (2020-03-01)

Choice of therapeutic tactics after failure of the first tumor necrosis factor-α inhibitor
by: N. V. Chichasova
Published: (2017-09-01)

TUMOR NECROSIS FACTOR-α INHIBITORS IN THE TREATMENT OF AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS
by: S. A. Lapshina, et al.
Published: (2016-09-01)

Pathogenetic role of tumor necrosis factor (TNF-α) for the development of peritoneal tuberculosis in an experiment
by: D. V. Plotkin, et al.
Published: (2021-11-01)

TUMOR NECROSIS FACTOR-α MEMBRANE-BOUND AND SOLUBLE RECEPTORS IN NORM AND IN RHEUMATOID ARTHRITIS
by: A. A. Alshevskaya, et al.
Published: (2012-05-01)

Validation of determination of human α-amylase activity for patients with pancreatic diseas
by: K. A. Cheremisina, et al.
Published: (2021-08-01)

Fuzzy α-modularity in fuzzy α-Lattices
by: Payal A. Khubchandani, et al.
Published: (2023-06-01)

How real is the long-lasting effect of tumor necrosis factor α inhibitors? Focus on immunogenicity
by: D.E. Karateev
Published: (2014-05-01)

Efficacy of tumor necrosis factor-α inhibitors in the treatment of various immunoinflammatory diseases: focus on immunogenicity
by: T. Yu. Nuriahmetova, et al.
Published: (2023-08-01)

Impact of therapy with tumor necrosis factor-α inhibitors on the working ability of patients with ankylosing spondylitis
by: Sh. F. Erdes, et al.
Published: (2016-03-01)

Tumor necrosis factor-α inhibitors and their effects on cardiovascular risk factorsin patients with rheumatoid arthritis
by: O G Lineva, et al.
Published: (2010-02-01)

INHIBITOR OF SYNTHESIS OF TUMOR NECROSIS FACTOR-Α, PENTOXIFYLLINE, IN COMBINED THERAPY OF THE CHRONIC HEART FAILURE
by: O. P. Dudarenko, et al.
Published: (2016-01-01)

The Role of MicroRNAs in Estrogen Receptor α-Positive Human Breast Cancer
by: Yamashita, Hiroko, et al.
Published: (2011)

Acute pharmacological effects of α-PVP in humans: a naturalistic observational study
by: Georgina De la Rosa, et al.
Published: (2025-07-01)

The survival rate of therapy with tumor necrosis factor-αinhibitors: main causes and drug substitution tactics
by: E. V. Igolkina, et al.
Published: (2018-12-01)

IMPACT OF THE THERAPY WITH TUMOR NECROSIS FACTOR α INHIBITORS ON THE FREQUENCY OF UVEITIS EXACERBATIONS IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: Alla A Godzenko, et al.
Published: (2014-03-01)

Activation of interferon-α signaling by resveratrol, genistein and quercetin
by: O. A. Vlasova, et al.
Published: (2019-02-01)

Determination of α+nucleus optical potential relevant for p-process study from the natIn(α, α) elastic scattering
by: Basak Dipali, et al.
Published: (2025-01-01)

Antioxidant Impact on Specific Antiviral Activity of Human Recombinant Interferon α-2b with Respect to Herpes simplex in Cell Culture
by: A. N. Vasilyev
Published: (2020-05-01)

Myricetin and chlorogenic acid from globe artichoke (Cynara cardunculus var. scolymus) as negative modulators of human Interferon I-α
by: Rosana Rotondo, et al.
Published: (2025-07-01)

Ozonolysis of α-amino-α/-hydroxymethyl-4-nitroacetophenone in the liquid phase
by: G. A. Galstyan
Published: (2017-04-01)

Clinical significance of tumor necrosis factor-α inhibitors in the treatment of sciatica: a systematic review and meta-analysis.
by: Yun Fu Wang, et al.
Published: (2014-01-01)

Evaluation of Serum Interleukin-33 and Tumor Necrosis Factor-α Levels in Patients with Psoriasis: Correlation with Disease Severity
by: Tanya Kamil Mohammed Gharib, et al.
Published: (2025-07-01)

Understanding and addressing anti-drug antibody formation in tumor necrosis factor-α inhibitor therapy for ankylosing spondylitis
by: Tae-Jong Kim
Published: (2025-07-01)

Expression of Tumor Necrosis Factor-Alpha (TNF-α TNF-α Converting Enzyme and Matrix Metalloproteinase-3 in SAPHO Syndrome Synovium - A Rare Case Accompanied by Acrodermatitis Continua of Hallopeau: A Case Report and Review of Anti-TNF-α Therapy
by: Komiya, Koichiro, et al.
Published: (2012)

Interferon-α and thymosin-α1 plus tislelizumab enhance CD8+ T cell cytotoxicity toward pancreatic ductal adenocarcinoma
by: Shun Deng, et al.
Published: (2025-08-01)

Association of <i>Helicobacter pylori</i> with Serum HIF-1α, HIF-2α, and Human Transmembrane Prolyl 4-Hydroxylase Activity in Patients with Chronic Gastritis
by: Sefa Ergün, et al.
Published: (2025-06-01)

APPLICATION OF INTERFERON-α FOR RESPIRATORY INFECTION IN CHILDREN WITH CHRONIC GLOMERULONEPHRITIS
by: Z.M. Enikeeva, et al.
Published: (2007-10-01)

EFFICACY OF INTRAPERITONEAL INTERFERON-α ADMINISTRATION FOR TREATMENT OF ENDOMETRIOSIS IN RATS
by: R. V. Pavlov, et al.
Published: (2014-07-01)

Human Leukocyte Antigen Class II in Stimulated Polymorphnuclear Neutrophils
by: Abdel-Salam, Bahaa K. A.
Published: (2012)

TAK-653 Reverses Core Depressive Symptoms in Chronic Stress-Induced Monkey Model
by: Ling Li, et al.
Published: (2025-06-01)